Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model
Identifieur interne : 000261 ( Istex/Curation ); précédent : 000260; suivant : 000262Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model
Auteurs : Donato A. Di Monte [États-Unis] ; Alison Mccormack [États-Unis, Suède] ; Giselle Petzinger [États-Unis] ; Ann Marie Janson [États-Unis, Suède] ; Maryka Quik [États-Unis] ; William J. Langston [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2000-05.
English descriptors
- KwdEn :
Abstract
Presynaptic denervation is likely to play an important role in the pathophysiology of dyskinesias that develop after levodopa administration to patients with Parkinson's disease. In this study, the thresholds of nigrostriatal damage necessary for the occurrence of parkinsonism and levodopa‐induced involuntary movements were compared in squirrel monkeys lesioned with 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP). Animals treated with a regimen of MPTP that caused parkinsonism displayed ≥95% striatal dopamine depletion, 90% reduction of striatal dopamine uptake sites, and 70% nigral neuronal loss. Levodopa administration ameliorated the parkinsonian signs of these monkeys but also induced dyskinesias. A separate group of animals was treated with a milder MPTP regimen that caused 60%–70% striatal dopamine depletion, a 50% decrease in dopamine transporter, and 40% loss of dopaminergic nigral neurons. While these monkeys displayed no behavioral signs of parkinsonism, they all became dyskinetic after levodopa administration. The priming effect of levodopa, that is, the recurrence of dyskinesias in animals previously exposed to the drug, was compared in severely versus mildly lesioned monkeys. When severely injured parkinsonian animals underwent a second cycle of levodopa treatment, they immediately and consistently developed involuntary movements. In contrast, the recurrence of dyskinesias in primed monkeys with a partial nigrostriatal lesion required several levodopa administrations and remained relatively sporadic. The data indicate that moderate nigrostriatal damage which does not induce clinical parkinsonism predisposes to levodopa‐induced dyskinesias. Once dyskinesias have been induced, the severity of denervation may enhance the sensitivity to subsequent levodopa exposures.
Url:
DOI: 10.1002/1531-8257(200005)15:3<459::AID-MDS1006>3.0.CO;2-3
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000261
Links to Exploration step
ISTEX:D13248DD2462D4AB89728A6C73E0B4B654F8743ALe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model</title>
<author><name sortKey="Di Monte, Donato A" sort="Di Monte, Donato A" uniqKey="Di Monte D" first="Donato A." last="Di Monte">Donato A. Di Monte</name>
<affiliation wicri:level="1"><mods:affiliation>The Parkinson's Institute, Sunnyvale, California, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Parkinson's Institute, Sunnyvale, California</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mccormack, Alison" sort="Mccormack, Alison" uniqKey="Mccormack A" first="Alison" last="Mccormack">Alison Mccormack</name>
<affiliation wicri:level="1"><mods:affiliation>The Parkinson's Institute, Sunnyvale, California, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Parkinson's Institute, Sunnyvale, California</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>Department of Neuroscience, Karolinska Institute, Stockholm, Sweden</mods:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Department of Neuroscience, Karolinska Institute, Stockholm</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Petzinger, Giselle" sort="Petzinger, Giselle" uniqKey="Petzinger G" first="Giselle" last="Petzinger">Giselle Petzinger</name>
<affiliation wicri:level="1"><mods:affiliation>The Parkinson's Institute, Sunnyvale, California, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Parkinson's Institute, Sunnyvale, California</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Janson, Ann Marie" sort="Janson, Ann Marie" uniqKey="Janson A" first="Ann Marie" last="Janson">Ann Marie Janson</name>
<affiliation wicri:level="1"><mods:affiliation>The Parkinson's Institute, Sunnyvale, California, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Parkinson's Institute, Sunnyvale, California</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>Department of Neuroscience, Karolinska Institute, Stockholm, Sweden</mods:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Department of Neuroscience, Karolinska Institute, Stockholm</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Quik, Maryka" sort="Quik, Maryka" uniqKey="Quik M" first="Maryka" last="Quik">Maryka Quik</name>
<affiliation wicri:level="1"><mods:affiliation>The Parkinson's Institute, Sunnyvale, California, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Parkinson's Institute, Sunnyvale, California</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Langston, William J" sort="Langston, William J" uniqKey="Langston W" first="William J." last="Langston">William J. Langston</name>
<affiliation wicri:level="1"><mods:affiliation>The Parkinson's Institute, Sunnyvale, California, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Parkinson's Institute, Sunnyvale, California</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:D13248DD2462D4AB89728A6C73E0B4B654F8743A</idno>
<date when="2000" year="2000">2000</date>
<idno type="doi">10.1002/1531-8257(200005)15:3<459::AID-MDS1006>3.0.CO;2-3</idno>
<idno type="url">https://api.istex.fr/document/D13248DD2462D4AB89728A6C73E0B4B654F8743A/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000261</idno>
<idno type="wicri:Area/Istex/Curation">000261</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model</title>
<author><name sortKey="Di Monte, Donato A" sort="Di Monte, Donato A" uniqKey="Di Monte D" first="Donato A." last="Di Monte">Donato A. Di Monte</name>
<affiliation wicri:level="1"><mods:affiliation>The Parkinson's Institute, Sunnyvale, California, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Parkinson's Institute, Sunnyvale, California</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mccormack, Alison" sort="Mccormack, Alison" uniqKey="Mccormack A" first="Alison" last="Mccormack">Alison Mccormack</name>
<affiliation wicri:level="1"><mods:affiliation>The Parkinson's Institute, Sunnyvale, California, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Parkinson's Institute, Sunnyvale, California</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>Department of Neuroscience, Karolinska Institute, Stockholm, Sweden</mods:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Department of Neuroscience, Karolinska Institute, Stockholm</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Petzinger, Giselle" sort="Petzinger, Giselle" uniqKey="Petzinger G" first="Giselle" last="Petzinger">Giselle Petzinger</name>
<affiliation wicri:level="1"><mods:affiliation>The Parkinson's Institute, Sunnyvale, California, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Parkinson's Institute, Sunnyvale, California</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Janson, Ann Marie" sort="Janson, Ann Marie" uniqKey="Janson A" first="Ann Marie" last="Janson">Ann Marie Janson</name>
<affiliation wicri:level="1"><mods:affiliation>The Parkinson's Institute, Sunnyvale, California, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Parkinson's Institute, Sunnyvale, California</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>Department of Neuroscience, Karolinska Institute, Stockholm, Sweden</mods:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Department of Neuroscience, Karolinska Institute, Stockholm</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Quik, Maryka" sort="Quik, Maryka" uniqKey="Quik M" first="Maryka" last="Quik">Maryka Quik</name>
<affiliation wicri:level="1"><mods:affiliation>The Parkinson's Institute, Sunnyvale, California, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Parkinson's Institute, Sunnyvale, California</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Langston, William J" sort="Langston, William J" uniqKey="Langston W" first="William J." last="Langston">William J. Langston</name>
<affiliation wicri:level="1"><mods:affiliation>The Parkinson's Institute, Sunnyvale, California, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Parkinson's Institute, Sunnyvale, California</wicri:regionArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>John Wiley & Sons, Inc.</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="2000-05">2000-05</date>
<biblScope unit="vol">15</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="459">459</biblScope>
<biblScope unit="page" to="466">466</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">D13248DD2462D4AB89728A6C73E0B4B654F8743A</idno>
<idno type="DOI">10.1002/1531-8257(200005)15:3<459::AID-MDS1006>3.0.CO;2-3</idno>
<idno type="ArticleID">MDS1006</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Dopamine</term>
<term>Dyskinesias</term>
<term>Levodopa</term>
<term>MPTP</term>
<term>Monkeys</term>
<term>Parkinson's disease</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Presynaptic denervation is likely to play an important role in the pathophysiology of dyskinesias that develop after levodopa administration to patients with Parkinson's disease. In this study, the thresholds of nigrostriatal damage necessary for the occurrence of parkinsonism and levodopa‐induced involuntary movements were compared in squirrel monkeys lesioned with 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP). Animals treated with a regimen of MPTP that caused parkinsonism displayed ≥95% striatal dopamine depletion, 90% reduction of striatal dopamine uptake sites, and 70% nigral neuronal loss. Levodopa administration ameliorated the parkinsonian signs of these monkeys but also induced dyskinesias. A separate group of animals was treated with a milder MPTP regimen that caused 60%–70% striatal dopamine depletion, a 50% decrease in dopamine transporter, and 40% loss of dopaminergic nigral neurons. While these monkeys displayed no behavioral signs of parkinsonism, they all became dyskinetic after levodopa administration. The priming effect of levodopa, that is, the recurrence of dyskinesias in animals previously exposed to the drug, was compared in severely versus mildly lesioned monkeys. When severely injured parkinsonian animals underwent a second cycle of levodopa treatment, they immediately and consistently developed involuntary movements. In contrast, the recurrence of dyskinesias in primed monkeys with a partial nigrostriatal lesion required several levodopa administrations and remained relatively sporadic. The data indicate that moderate nigrostriatal damage which does not induce clinical parkinsonism predisposes to levodopa‐induced dyskinesias. Once dyskinesias have been induced, the severity of denervation may enhance the sensitivity to subsequent levodopa exposures.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000261 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 000261 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Istex |étape= Curation |type= RBID |clé= ISTEX:D13248DD2462D4AB89728A6C73E0B4B654F8743A |texte= Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |